| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 78.14B | 70.83B | 62.36B | 53.65B | 49.33B |
| Gross Profit | 48.27B | 44.03B | 39.03B | 32.32B | 30.40B |
| EBITDA | 21.85B | 27.98B | 21.15B | 16.33B | 14.95B |
| Net Income | 13.24B | 15.60B | 10.24B | 7.59B | 7.72B |
Balance Sheet | |||||
| Total Assets | 124.35B | 112.61B | 92.23B | 69.19B | 62.67B |
| Cash, Cash Equivalents and Short-Term Investments | 39.05B | 34.30B | 38.64B | 28.30B | 26.90B |
| Total Debt | 33.44B | 28.12B | 21.47B | 19.50B | 18.32B |
| Total Liabilities | 53.57B | 45.88B | 36.22B | 31.36B | 31.00B |
| Stockholders Equity | 64.15B | 61.73B | 51.46B | 34.40B | 28.92B |
Cash Flow | |||||
| Free Cash Flow | 17.88B | 13.28B | 18.31B | 10.41B | 10.37B |
| Operating Cash Flow | 20.39B | 16.74B | 19.63B | 12.15B | 11.86B |
| Investing Cash Flow | -6.55B | -14.86B | -25.79B | -4.77B | -4.67B |
| Financing Cash Flow | -13.02B | -5.76B | 3.47B | -7.84B | -4.95B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$55.99B | 15.11 | 10.51% | 3.83% | 4.12% | -7.17% | |
69 Neutral | HK$5.21B | 5.38 | 19.99% | 7.41% | 11.18% | -1.06% | |
68 Neutral | HK$209.86B | 15.20 | 23.75% | 3.10% | 13.55% | 13.30% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | HK$1.09B | 8.51 | 18.91% | ― | ― | ― | |
41 Neutral | HK$112.64M | -2.81 | -26.02% | ― | 157.17% | 39.38% | |
41 Neutral | HK$409.59M | -4.63 | -7.45% | ― | -5.36% | -63.16% |